The Net Margin of HLS Therapeutics Inc (HLS.TO) is -34.71%.
Net Margin measures the percentage of net income derived from total revenue after all expenses. It signals how much actual profit a company retains from its sales.
Date | Value |
---|---|
2024-12-31 | -34.71% |
2023-12-31 | -43.65% |
2022-12-31 | -38.37% |
2021-12-31 | -21.83% |
2020-12-31 | -27.27% |
2019-12-31 | -36.16% |
2018-12-31 | -40.39% |
2017-12-31 | -8.12% |